Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website
Kimberlee Trzeciak Deputy Commissioner for Policy, Legislation, and International Affairs of FDA | Official Website
This is a 200% increase over the number of companies inspected in the previous quarter, when three companies received three inspections.
The companies inspected were involved in the Food and Cosmetics sector.
There were four companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Five should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Ajinomoto Foods North America, Inc. | Food and Cosmetics | 07/27/2023 | No Action Indicated (NAI) |
Cametco, Inc. | Food and Cosmetics | 07/10/2023 | Voluntary Action Indicated (VAI) |
Classic Foods, Ltd. | Food and Cosmetics | 08/04/2023 | Voluntary Action Indicated (VAI) |
HTO Nevada, Inc. | Food and Cosmetics | 08/17/2023 | Voluntary Action Indicated (VAI) |
OIA SCM Global - Bybee Distribution Facility, Inc. | Food and Cosmetics | 07/12/2023 | No Action Indicated (NAI) |
Strebin Farms, LLC | Food and Cosmetics | 07/13/2023 | No Action Indicated (NAI) |
The Revelry Group, LLC | Food and Cosmetics | 08/10/2023 | Voluntary Action Indicated (VAI) |
Unbound Pickling, LLC | Food and Cosmetics | 08/11/2023 | Voluntary Action Indicated (VAI) |
Yoshida Foods International, LLC | Food and Cosmetics | 09/15/2023 | No Action Indicated (NAI) |